Crowdonomics
Kurve Therapeutics, Inc.

Reg A+ · Equity · May 2022

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $42.4M max
0% of ceiling
Investors
—
—
Estimated pre-money
$291.8M
—

Financials disclosed in this offering

FY2021 · hover for source
$71K
−$65K
FY2021
RevenueNet income
Metric
FY2021 audited
Income statement
Revenue
$70,700
Cost of goods sold
$128,344
Gross margin
-82%
Net income
-$65,427
Balance sheet
Cash
$373,804
Accounts receivable
$15,000
Total assets
$640,574
Long-term debt
$507,500
Total liabilities
$606,726
Other
Headcount
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Jul 29, 2022
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$291.8M
Price / share$5.80
Shares offered8,620,689

Estimated, not stated: $5.80 × 50,308,155 securities outstanding.

Offering details

Target—
Max$42,420,183
Min investment—
OpenedMay 27, 2022
Deadline—
Days active1,597

Links & provenance

Source: SEC EDGAR
0001930260-22-000001
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.